Sodium Chloride Injection
Product Images NDC 0338-0182

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 0338-0182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Assembly 1-3 (Image 01)

An instructional diagram showing the preparation steps for using a vial with a mini-bag plus container for intravenous injection. The first panel illustrates removing the vial cover and disinfecting the stopper. The second panel depicts peeling off the foil cover from the mini-bag, inspecting the adaptor for moisture, and discarding if found. The third panel demonstrates placing the vial upright, holding it firmly, and pushing the adaptor down until the vial snaps in place without twisting.*

FDA Label Image

Reconstitution 4-6 (Image 02)

Instructional illustrations showing steps 4 through 6 for mixing a drug vial with an intravenous bag. Step 4 depicts squeezing the bag to check the vial and breaking the seal. Step 5 shows holding the bag with the vial down, squeezing to fill the vial halfway, and shaking to suspend the drug. Step 6 illustrates holding the bag and vial upside down, squeezing to force air into the vial, releasing to draw the drug into the bag, and repeating until the vial is empty, ensuring the drug is completely dissolved.*

FDA Label Image

Representative Container Lbl 0338-0182-04 (Image 03)

Label for Sodium Chloride Injection USP 450 mg/50 mL intravenous injection in a mini-bag plus container by Baxter Healthcare Corporation. The label indicates it is a sterile, single-dose, 50 mL container for use with a 13 mm vial, containing sodium chloride at 0.9% concentration, with pH 5.0 and osmolarity 308 mOsmol/L. The product is Rx only and made in the USA.*

FDA Label Image

Representative Container Lbl 0338-0192-04 (Image 04)

Label for Sodium Chloride Injection USP, 0.9%, 450 mg per 50 mL intravenous injection by Baxter Healthcare Corporation. The label indicates a 50 mL VIAFLEX single-dose MINI-BAG PLUS container for use with a 20 mm vial. It includes usage instructions and important cautions such as sterility and compatibility warnings, and states it is Rx only.*

FDA Label Image

Representative Container Lbl 0338-0186-04 (Image 05)

Label for 0.9% Sodium Chloride Injection USP, 100 mL Mini-Bag Plus container designed for use with a 13 mm vial. The product contains 900 mg sodium chloride per 100 mL, is sterile, nonpyrogenic, and intended for intravenous use. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA. Instructions include breaking the seal and mixing before use.*

FDA Label Image

Representative Container Lbl 0338-0196-04 (Image 06)

Label for 0.9% Sodium Chloride Injection USP, 100 mL MINI-BAG PLUS container designed for use with a 20 mm vial. The injection provides 900 mg sodium per 100 mL with pH 5.0 (4.5 to 7.0), sodium chloride 15 mEq/L, and osmolality 308 mOsmol/L. Produced by Baxter Healthcare Corporation, Deerfield, IL, USA, this sterile, nonpyrogenic intravenous solution is single dose and for prescription use only. The label includes directions to break seal and mix before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.